Why is Vaishali Pharma falling/rising?

As of 09-Sep, Vaishali Pharma Ltd's stock price is currently at 12.17, reflecting a decrease of 0.18, or 1.46%. The stock has underperformed its sector today by 2.09%, and while it is higher than its 5-day moving average, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a slight decline of 0.16%, and it has experienced a significant drop of 30.42% year-to-date. The company's financial health is concerning, with a weak long-term fundamental strength indicated by a -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA. Additionally, the company's ability to service its debt is weak, as evidenced by a poor EBIT to Interest ratio of 1.68, and its profitability per unit of shareholders' funds is low, with an average Return on Equity of 7.89%.
In the broader market context, the Sensex has increased by 1.18% over the past week, contrasting with Vaishali Pharma's decline. The stock has underperformed the benchmark index significantly over various periods, including a 36.84% drop over the past year, while the Sensex has remained relatively flat with a -0.27% return. This underperformance is compounded by the company's flat results in June, where its profit after tax fell by 24.7%. The rising investor participation, indicated by a 52.91% increase in delivery volume, suggests some interest, but overall, the stock's negative financial indicators and poor performance relative to the market contribute to its downward movement.